Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 201.29

+0.2%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (20492)	5/11/1998 6:57:00 PM
From: Andreas Helke	Read Replies (3) of 32384

The buyout of SRGN removes an important competitor for the treatment of CTCL. They will probably get higher prices for their drugs after buying out the competition for CTCL treatment. That should help to increase Ligands market cap. Maybe Ligand wants to make sure that the 1999 earnings are closer to 80 than to 8 cents. I am still astonished that a treatment of a rare disease like CTCL makes a significant difference to the earnings of a medium sized biotech company. Andreas

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next